Literature DB >> 10871554

Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders.

R J Playford1, C E Macdonald, W S Johnson.   

Abstract

Colostrum is the specific first diet of mammalian neonates and is rich in immunoglobulins, antimicrobial peptides, and growth factors. In this article we review some of these constituents of human and bovine colostrum in comparison with those of mature milk. Recent studies suggest that colostral fractions, or individual peptides present in colostrum, might be useful for the treatment of a wide variety of gastrointestinal conditions, including inflammatory bowel disease, nonsteroidal antiinflammatory drug-induced gut injury, and chemotherapy-induced mucositis. We therefore discuss the therapeutic possibilities of using whole colostrum, or individual peptides present in colostrum, for the treatment of various gastrointestinal diseases and the relative merits of the 2 approaches.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10871554     DOI: 10.1093/ajcn/72.1.5

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  50 in total

1.  Hyperimmune bovine colostrum as a low-cost, large-scale source of antibodies with broad neutralizing activity for HIV-1 envelope with potential use in microbicides.

Authors:  Marit Kramski; Rob J Center; Adam K Wheatley; Jonathan C Jacobson; Marina R Alexander; Grant Rawlin; Damian F J Purcell
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

2.  The effect of dietary bovine colostrum on respiratory syncytial virus infection and immune responses following the infection in the mouse.

Authors:  Mei Ling Xu; Hyoung Jin Kim; Ga Ram Wi; Hong-Jin Kim
Journal:  J Microbiol       Date:  2015-08-27       Impact factor: 3.422

3.  Could the GI tract be a better portal for antibody therapy?

Authors:  S J Green; Jon Brendsel
Journal:  Gut       Date:  2006-11       Impact factor: 23.059

Review 4.  Bioactive peptides and proteins from foods: indication for health effects.

Authors:  Niels Peter Möller; Katharina Elisabeth Scholz-Ahrens; Nils Roos; Jürgen Schrezenmeir
Journal:  Eur J Nutr       Date:  2008-05-27       Impact factor: 5.614

5.  The weaned pig as a model for Doxorubicin-induced mucositis.

Authors:  Jamee Martin; Scott C Howard; Asha Pillai; Peter Vogel; Anjaparavanda P Naren; Steven Davis; Karen Ringwald-Smith; Karyl Buddington; Randal K Buddington
Journal:  Chemotherapy       Date:  2014-10-21       Impact factor: 2.544

6.  Conversation With Michael F Roizen, MD: Colostrum and Immunity.

Authors:  Dick Benson
Journal:  Integr Med (Encinitas)       Date:  2020-06

Review 7.  Dietary factors in the modulation of inflammatory bowel disease activity.

Authors:  Shinil Shah
Journal:  MedGenMed       Date:  2007-03-27

8.  Cow's milk allergy and neonatal short bowel syndrome: comorbidity or true association?

Authors:  A Diamanti; A G Fiocchi; T Capriati; F Panetta; N Pucci; F Bellucci; G Torre
Journal:  Eur J Clin Nutr       Date:  2014-09-03       Impact factor: 4.016

9.  Enhanced membrane-tethered mucin 3 (MUC3) expression by a tetrameric branched peptide with a conserved TFLK motif inhibits bacteria adherence.

Authors:  Qiong Pan; Yin Tian; Xiaohuan Li; Jun Ye; Yun Liu; Lili Song; Yongtao Yang; Rong Zhu; Yonghong He; Lei Chen; Wensheng Chen; Xuhu Mao; Zhihong Peng; Rongquan Wang
Journal:  J Biol Chem       Date:  2013-01-10       Impact factor: 5.157

10.  Development and experimental application of an HPLC procedure for the determination of capsaicin and dihydrocapsaicin in serum samples from human subjects.

Authors:  Thomas Hartley; Brian Stevens; Kiran D K Ahuja; Madeleine J Ball
Journal:  Indian J Clin Biochem       Date:  2013-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.